APA (7th ed.) Citation

Nagy, E., Gajjar, K. B., Patel, I. I., Taylor, S., Martin-Hirsch, P. L., Stringfellow, H. F., . . . Phillips, D. H. (2014). MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases. British Journal of Cancer, 110(12), 2874. https://doi.org/10.1038/bjc.2014.263

Chicago Style (17th ed.) Citation

Nagy, E., K B. Gajjar, I I. Patel, S. Taylor, P L. Martin-Hirsch, H F. Stringfellow, F L. Martin, and D H. Phillips. "MGMT Promoter Hypermethylation and K-RAS, PTEN and TP53 Mutations in Tamoxifen-exposed and Non-exposed Endometrial Cancer Cases." British Journal of Cancer 110, no. 12 (2014): 2874. https://doi.org/10.1038/bjc.2014.263.

MLA (9th ed.) Citation

Nagy, E., et al. "MGMT Promoter Hypermethylation and K-RAS, PTEN and TP53 Mutations in Tamoxifen-exposed and Non-exposed Endometrial Cancer Cases." British Journal of Cancer, vol. 110, no. 12, 2014, p. 2874, https://doi.org/10.1038/bjc.2014.263.